Pentwater Capital Management’s Allergan Inc AGN Stock Holding History

Pentwater Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-100,000	Closed	-$21.3M	–	204
2014 Q4	$21.3M	Hold	100,000	–	–	0.15%	64
2014 Q3	$17.8M	Buy	+100,000	New	+$16.6M	0.17%	77

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Pentwater Capital Management's AGN Position: Q1 2015 in Review

Pentwater Capital Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 5,589,600 shares — an estimated $1.19B sold.

Pentwater Capital Management first reported a position in AGN in Q2 2014 and held it in 3 quarters. The position peaked at $1.19B in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Pentwater Capital Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Pentwater Capital Management sold 5,589,600 Allergan Inc shares in Q1 2015, an estimated $1.19B.
Pentwater Capital Management first reported a position in Allergan Inc in Q2 2014 and held it in 3 quarters.
Pentwater Capital Management's Allergan Inc position peaked at $1.19B in Q4 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Pentwater Capital Management's 13F filing for Q1 2015, filed 15 May 2015.